Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume by Product, Animal & Application The global veterinary imaging market will witness a robust CAGR of 7.3%, valued at $1.58 billion in 2021, expected to appreciate and reach $3.0 billion by 2030, confirms Strategic Market Research. North America acquired almost 45.5 % of the global market and is expected to retain its dominance as the largest industry from 2020-2030. Imagining is a kind of test that produces detailed images of internal organs. X-rays (high-energy radiation), ultrasound (high-energy sound waves), radio waves, and radioactive chemicals are used in imaging processes. They may aid in the diagnosis of disease, the planning of treatment, or the evaluation of treatment effectiveness. Many imaging technologies have been developed to diagnose human diseases, and many have been modified for use in animals. Veterinary imaging is a process for obtaining diagnostic pictures of an animal's body to diagnose chronic illnesses. According to Countryside Veterinary Clinic, diabetes affects 1 in every 500 dogs and 1 in every 200 cats in their lifespan, and the numbers are rising. Over ten years, the prevalence of the condition increased by about 80% in dogs and 18% in cats, according to the State of Pet Health Report. Furthermore, according to the American Veterinary Medical Association, diabetes can pound dogs and cats at any age. Diabetic dogs are typically 4 to 14 years old, most diagnosed between the ages of 7 and 10. The majority of diabetic cats are over the age of six. Female dogs are more prone to get diabetes as compared to male dogs. Most imaging modalities provide a wealth of information in a non-invasive and cost-effective way while ensuring that the illness process is not altered or that the pet is not in any discomfort. However, some of these treatments are carried out in facilities constructed specifically for their usage due to the complexity and cost of the equipment and instruments. A hike in the adoption rate for pets, a rise in the breakout of various infectious diseases, increasing demand for various diagnostic devices, and an increase in pet care spending are some of the prominent drivers of the market. Key Drivers - Growing Demand for Diagnostic Devices and a Rise in the Healthcare Expenditure The rising demand for diagnostic devices for the appropriate treatment of small pets such as cats and dogs drives the veterinary imaging industry. Obesity is a common problem among pets in the United States, according to the Association for Pet Obesity Prevention, with 60 % of all cats and 56 % of all dogs classed as obese or overweight. These imaging devices aid in diagnosing nasal/sinus disorders by distinguishing between neoplasia and rhinitis and directing biopsy test findings. Furthermore, the growing level of pet healthcare expenditure would boost the growth of the veterinary imaging market. A pet insurance plan generally inculcates all the diagnostic tests like CT and MRIs to detect neurological or musculoskeletal conditions and others. According to the American Pet Products Association (APPA), Americans spent $4.3 billion more on pet items in 2020 than in 2019. Pet food, pet insurance, veterinarian care, supplies/over-the-counter medications, companion animal diagnostic services, etc., are gaining popularity as people are spending more and more in these days. The North American Pet Health Insurance Association (NAPHIA) reported that gross written premiums for pet health insurance in the US reached $1.99 billion in 2020, up 27.5 % from $1.56 billion in 2019. The market grew at an annual pace of roughly 24.2 % from 2016 to 2020. The total number of insured pets had climbed to 3.1 million by 2020. The market has been growing at around 24.2 % each year on average. Restraints - High Maintenance Costs of Equipment, Lesser Number of Skilled Professionals, and Lack of Awareness Lack of awareness, high maintenance costs, and shortage of skilled practitioners in developing areas limit the market expansion. Opportunities - The Rise in the Number of Pet Owners, Rapid Urbanization, Increase in Disposable Income, and Improved R&D There has been a spectacular surge in companion animal ownership worldwide, particularly in emerging countries such as Asia and Latin America. These areas provide a plethora of prospects due to rapid urbanization and an increase in disposable income, and increasing pet ownership has resulted in greater access to improved animal treatment and increased spending capacity on the part of owners. According to a survey by Rakuten Insight, 59% of people in Asia (China, India, Hong Kong, Indonesia, South Korea, Japan, Malaysia, Singapore, Thailand, Taiwan & Vietnam) own a pet, yet there are significant disparities. On the one hand, Hong Kong has a dog ownership rate of 16%, compared to 47% in Thailand, and the Philippines has the highest rate of 67%. On average, one-third of the population (32%) believes that dogs are man's best friend. Cats came in second with 26% of pet ownership, except for Indonesia and Malaysia, where cat ownership (47% and 34%, respectively) outpaced dog ownership (10% and 20%, respectively). Fish were the 3rd most popular pet, with 15% of respondents owning one, and 41% of respondents said they are not currently raising any pets. Many of the region's veterinary clinics embrace technologically advanced solutions (fluoroscopy, ultrasonography, echocardiography in veterinary medicine) common among veterinarians in emerging countries. The livestock industry's need for veterinary services and growing animal health spending will likely drive market expansion. Requests for World Bank assistance for livestock operations have increased dramatically in the last three years, from an average of US$150 million in annual funding commitments at the beginning of the decade to about US$700 million in new lending yearly. The most developed regions include Africa, South Asia, and Central Asia. The World Bank now has active livestock investments worth $1.9 billion. As a result, these variables are predicted to bring up profitable business prospects for big firms and new market entrants. For example, companies like Antech imaging services, boulder veterinary imaging, boneyard veterinary imaging, bush advanced veterinary imaging, and BCF ultrasound provide next-gen technologies for advanced imaging, ultrasonic imaging, etc. Apart from that, rapid technological advancements are going on for mobile veterinary imaging and nuclear medicine imaging to examine the condition of tissue functioning and organs like the heart, abdominal wall, heart valves, blood vessels, lungs, liver, thyroid, etc. Market Analysis Of Different Segments Covered in the Report Based on Product Instrument X-ray Imaging (Radiography) Computed Radiography Direct (Capture) Radiography Film-based Radiography Ultrasound Imaging 3D/4D Ultrasound Imaging 2D Ultrasound Imaging Doppler Imaging Computed Tomography Imaging Video Endoscopy Imaging Single-slice CT Multi-slice CT MRI Other instruments Reagents X-Ray/CT Contrast Reagents MRI Contrast Regents Ultrasound Contrast Regents Nuclear Imaging Services Teleradiology Interventional Radiology & Endoscopy Advanced Imaging Services Veterinary PACS CVIS PACS RIS PACS Based on the Type of Animal Large Animals Small Companion Animals Others (Exotic Animals & Birds) Based on Applications Oncology Orthopedics and Traumatology Neurology Cardiology Other (ophthalmology & dentistry) Based on End-user Reference Laboratories Clinics Hospitals Others Regional Coverage Analysis North America The United States. Mexico Canada Rest of Northern America Europe The Netherlands France United Kingdom Italy Germany Russian Federation Spain Poland Rest of the European Countries AsiaPacific Japan Taiwan Australia China Republic of India Rest of Asia-Pacific (APAC) Latin America, Middle East, and Africa Brazil Argentina South Africa UAE Other parts of LAMEA Product Analysis & Insights The instruments category accounted for the greatest veterinary imaging market share because of its expansion of demand. Imaging instruments are essential items; therefore, their usage is likely to rise. This equipment help veterinarians diagnose fractures, tumors, abscesses due to infections, deformities, kidneys, and hemorrhages in animals. Periodontal disease (12.52 %), otitis externa (7.30 %), and obesity (7.07 %) are the most commonly diagnosed diseases in dogs in India, according to an article published in BMC Veterinary Research 2021. The most prevalent diseases in dogs in India were dental disorders (14.10 %), skin problems (12.58 %), and enteropathy (10.43 %). Because of their enhanced sensitivity and lower operating costs, demand for these devices is expected to rise. Because of their widespread use in clinical settings, veterinary picture archiving and communication systems (PACS) are expected to grow rapidly. Animal Type Analysis & Insights The small companion animal category led in 2020 owing to rising pet adoption as evidence of individuals obtaining favorable health advantages from their pets grew. Animals provide companionship, and this is especially advantageous for single persons. Pet ownership surged by 17 % among singles over six years but only 1.37 % among families. Pet ownership increased by 27.7% among unmarried men who live alone. According to a poll conducted by the Human-Animal Bond Research Institute, 74% of pet owners stated their pet improved their mental health. Researchers of Michigan State University discovered that dog owners are 34 % more likely than non-dog owners to walk 150 minutes weekly. The rising ownership of companions has increased the necessity for highly accurate and effective diagnostic solutions, which is projected to drive the market for imaging systems in the next years. Application Analysis & Insights The orthopedic and traumatology veterinary imaging applications made up most income. Growth in animal injuries, growing demand for precise diagnostic solutions, and the availability of animal care facilities all contribute to this segment's domination. In cancer, veterinary diagnostic imaging technologies offer a wide range of uses. According to the findings of the American Veterinary Medical Association, one out of every four dogs will acquire neoplasia at some point in their lives. Cancer affects about half of all dogs over the age of ten. Cancer affects dogs at a similar rate as it does people, but there is less data on cancer incidence in cats. In the United States, nearly 4.2 million dogs and 412 out of 100,000 cats are diagnosed with cancer yearly. This market is predicted to develop at a promising CAGR of roughly 7.0 % in the next years, owing to an increase in the frequency of cancer in animals and increased R&D activity in oncology. End-User Analysis & Insights As of 2020, veterinary hospitals had the highest revenue share. The demand for cost-effective, quick, and reliable diagnostic tools in animal healthcare drives the development of imaging technologies. According to a national pet owners poll done by finance website LendEDU, nearly half of all Americans spend the same amount or more on their pets' healthcare as they do on their own. Twenty % of respondents have gone into debt to care for their pets, with an average debt of $1,567. Advances in imaging technology like mobile technology for pet owners and cloud-based information management systems are examples of these improvements. The reference laboratory market is expected to grow at a 7.2 % CAGR. These laboratories provide thorough diagnostic testing to provide accurate findings and professional consulting services. Region Analysis & Insights North America and Europe dominated the veterinary imaging market. North America acquired almost 45.5 % of the global industry and is expected to retain its dominance as the largest industry over the speculated period. This dominant market position may be attributable to increased pet adoption and healthcare expenditure in the animal health segment. As per the National Pet Owners Survey conducted in 2021-2022, around 70% (or around 90.5 million) of families own a pet, which is an increase of nearly 67% compared to 2019. The United States pet expenditure market in 2021, summed up around USD 123.71 billion, a whopping 19% increase as compared to last year (USD 103.78 billion). In one of its studies, the American Society for the Prevention of Cruelty says that the pet adoption rate in North America has grown significantly. The Asia Pacific is predicted to be veterinary imaging's fastest-growing market due to increased healthcare expenditures and major companies' interest in investing in this industry. Veterinary Imaging Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market worth in 2021 USD 1.58 billion Forecasted revenue in 2030 USD 3.0 billion Growth rate CAGR of 7.3 % The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Animal Type, By Application, By End User, By Region. By Product Instruments, Reagents, Services, Veterinary PACS By Animal Type Small Companion Animals, Large Animals, Others (Including Exotic Animals and Birds) By Application Orthopaedics and Traumatology, Oncology, Cardiology, Neurology, Other (dentistry & ophthalmology) By End-User Hospitals/Clinics, Reference Laboratories, Others By Region European countries, Northern America, Latin America, Asia Pacific, MEA Country Scope US, Mexico, Canada, Germany, UK, France, China, Japan, India etc. Company Usability Profiles Koninklijke Philips N.V., Hitachi Ltd., Siemens Healthcare GmbH, FUJIFILM Corporation, PerkinElmer Inc., Clarius Mobile Health, Shenzhen Ricso Technology Co. Ltd., DRAMIÑSKI SA., Epica Animal Health Global Veterinary Imaging Market Competitive Landscape Analysis The competitive landscape analysis gives an overview of some prominent players operating in the industry. Product innovation and persistent R&D operations to create state-of-the-art technologies have catalyzed the market's growth. In the target market, there are many significant companies, and some of the industries are: Bruker General Electric Koninklijke Philips N.V. Hitachi Ltd. Siemens Healthcare GmbH FUJIFILM Corporation PerkinElmer Inc. Clarius Mobile Health Shenzhen Ricso Technology Co. Ltd. DRAMIÑSKI SA. Epica Animal Health ClearVet Digital Radiography Systems MinXray Inc. Hallmarq Veterinary Imaging Shantou Institute of Ultrasonic Instruments Co., Ltd Sonoscape Medical Corp. Reproscan Recent Developments: On Jan 2022, Clarius launched its 3rd generation wireless ultrasound scanner for veterinary professionals. The Artificial Intelligence enabled scanners with -powered imaging is equipped with various animal pre-sets to provide better care to an animal regardless of its size. On November 2021, Adaptix released the 3D Veterinary Imaging System, which the business claims can revolutionize dentistry and orthopedic imaging from both a clinical and cost standpoint. Adaptix's system fires very low-flux X-rays from many distinct points in a series, unlike a traditional 2D X-ray system, and this enables the system to reconstruct a stack of slices across the veterinary animals that can be viewed in the same way that coronal slices from a CT scan can be, with only a slight increase in dose over a single 2D X-ray. Adaptix allows each jaw side to be seen separately and clearly, making the process easier than obtaining many intraoral 2D X-ray images. On February 2021, FUJIFILM Medical Systems USA, Inc. introduced the first fully equipped VXR Veterinary X-Ray Room. The revolutionary design of this new X-ray room is intended for veterinarians who wish to convert to high-quality, low-dose X-rays using an economical, adaptable, simple-to-use, and easy-to-install system. On February, 2021, Fujifilm Corporation successfully launched the VXR Veterinary X-Ray Room, which is a Digital Radiography System used widely for Veterinary Imaging purposes. This technologically advanced system was designed especially for those veterinary professionals who wanted a transformation to low-dose and high-quality X-rays, which are affordable and easy to install. Various Devices Manufactured by Key Market Players Name Feature Key Player Logiq S7 This veterinary ultrasound system provides exceptional imaging on various parts of the veterinary bodies. GE Standing Equine Leg CT The innovative walk-in, walk-out floor level arrangement allows the standing sedated patient simple access and egress. With no general anesthetic necessary for the horse and low dosage radiation that allows the handler to stay in the room throughout, both the horse and the handler are safe. Hallmarq Veterinary Imaging ADVIA 120 Only hematology analyzers for humans and animals provide full multispecies hematology testing capabilities with realistic automation. The device has a high-throughput capacity of 120 samples per hour and advanced blood cell analysis technology. Siemens-healthineers Frequently Asked Question About This Report What is the veterinary imaging market growth? The global veterinary imaging market is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2021 to 2030 to reach USD 3.0 billion by 2030. How big is the global veterinary imaging market? The global veterinary imaging market size was $1.58 Bn in 2021 and is predicted to reach $3.0 Bn by 2030, with a CAGR of 7.3% during 2021 - 2030. What is the market value of the veterinary imaging market in 2021? Veterinary Imaging Market share in 2021 is $ 1.59 billion. What is the expected valuation of the veterinary imaging market by 2030? According to the veterinary imaging market trends, the veterinary imaging market is forecasted to reach a valuation of $ 3.0 billion by 2030 with a CAGR of 7.3 %. Which is the leading region in the veterinary imaging market? North America is leading the veterinary diagnostic imaging market. What is the total market size of the veterinary imaging market in 2021? Veterinary Imaging Market size in 2021 is $ 1.58 billion. Sources https://www.countrysideveterinaryclinic.org/services/dogs/blog/pet-diabetes-facts-know-keep-your-cat-or-dog-healthy https://www.avma.org/resources/pet-owners/petcare/diabetes-pets https://naphia.org/news/na-pet-health-insurance-market-more-than-doubles-in-four-years/ https://insight.rakuten.com/pet-ownership-in-asia/ 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Veterinary Imaging Market Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Market 4.2.1 market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 market, by region, 2021-2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 market, By Product, 2021-2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 market, By End-User, 2021-2030 (USD Million) 4.6 Application Business Analysis 4.6.1 market, By Application, 2021-2030 (USD Million) 4.6 Type of Animal Business Analysis 4.6.1 market, By Type of Animal, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 market PEST analysis 4.9.2 market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Type of Animal Analysis 5.11.1. Trends in Type of Animal (2014-2020) 5.11.2. Trends in Type of Animal (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Instrument 7.3.1. Instrument market, 2021-2030 (USD Million) 7.3.1.1 X-ray Imaging (Radiography) devices market, 2021-2030 (USD Million) 7.3.1.1.1 Computed Radiography market, 2021-2030 (USD Million) 7.3.1.1.2 Direct (Capture) Radiography market, 2021-2030 (USD Million) 7.3.1.1.3 Film-based Radiography market, 2021-2030 (USD Million) 7.3.1.2 Ultrasound Imaging market, 2021-2030 (USD Million) 7.3.1.2.1 3D/4D Ultrasound Imaging market, 2021-2030 (USD Million) 7.3.1.2.2 2D Ultrasound Imaging market, 2021-2030 (USD Million) 7.3.1.2.3 Doppler Imaging market, 2021-2030 (USD Million) 7.3.1.3 Computed Tomography Imaging market, 2021-2030 (USD Million) 7.3.1.3.1 Video Endoscopy Imaging market, 2021-2030 (USD Million) 7.3.1.3.2 Single-slice CT market, 2021-2030 (USD Million) 7.3.1.3.3 Multi-slice CT market, 2021-2030 (USD Million) 7.4.1.3.4 MRI market, 2021-2030 (USD Million) 7.4.1.3.5 Other instruments market, 2021-2030 (USD Million) 7.4. Reagents market, 2021-2030 (USD Million) 7.4.1. X-Ray/CT Contrast Reagents market, 2021-2030 (USD Million) 7.4.2. MRI Contrast Regents market, 2021-2030 (USD Million) 7.4.3. Ultrasound Contrast Regents market, 2021-2030 (USD Million) 7.4.4. Nuclear Imaging market, 2021-2030 (USD Million) 7.5. Services market, 2021-2030 (USD Million) 7.5.1 Teleradiology market, 2021-2030 (USD Million) 7.5.2 Interventional Radiology & Endoscopy market, 2021-2030 (USD Million) 7.5.3 Advanced Imaging Services market, 2021-2030 (USD Million) 7.6. Veterinary PACS market, 2021-2030 (USD Million) 7.6.1. CVIS PACS market, 2021-2030 (USD Million) 7.6.2 RIS PACS market, 2021-2030 (USD Million) 8. Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Reference Laboratories 8.3.1. Reference Laboratories market, 2021-2030 (USD Million) 8.4. Clinics 8.4.1. Clinics market, 2021-2030 (USD Million) 8.5. Hospitals 8.5.1. Hospitals market, 2021-2030 (USD Million) 9. Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Oncology 9.3.1. Oncology market, 2021-2030 (USD Million) 9.4. Orthopaedics and Traumatology 9.4.1. Orthopaedics and Traumatology market, 2021-2030 (USD Million) 9.5. Neurology 9.5.1. Neurology market, 2021-2030 (USD Million) 9.6. Cardiology 9.6.1. Cardiology market, 2021-2030 (USD Million) 9.7. Other (ophthalmology & dentistry) 9.7.1. Other (ophthalmology & dentistry) market, 2021-2030 (USD Million) 10. Market: By Type of Animal Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Large Animals 10.3.1. Large Animals market, 2021-2030 (USD Million) 10.4. Small Companion Animals 10.4.1. Small Companion Animals market, 2021-2030 (USD Million) 11. Market: Regional Outlook 11.1 North America 11.1.1. North America market, by By Product, 2021-2030 (USD Million) 11.1.2. North America market, by By End-User, 2021-2030 (USD Million) 11.1.3. North America market, by Type of Animal, 2021-2030 (USD Million) 11.1.4. North America market, by Country, 2021-2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. market, by By Product, 2021-2030 (USD Million) 11.1.4.1.2. U.S. market, by By End-User, 2021-2030 (USD Million) 11.1.4.1.3. U.S. market, by Type of Animal, 2021-2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada market, by By Product, 2021-2030 (USD Million) 11.1.4.2.2. Canada market, by By End-User, 2021-2030 (USD Million) 11.1.4.2.3. Canada market, by Type of Animal, 2021-2030 (USD Million) 11.2. Europe 11.2.1. Europe market, by By Product, 2021-2030 (USD Million) 11.2.2. Europe market, by By End-User, 2021-2030 (USD Million) 11.2.3. Europe market, by Type of Animal, 2021-2030 (USD Million) 11.2.4. Europe market, by country, 2021-2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. market, by By Product, 2021-2030 (USD Million) 11.2.4.1.2. U.K. market, by By End-User, 2021-2030 (USD Million) 11.2.4.1.3. U.K. market, by Type of Animal, 2021-2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany market, by By Product, 2021-2030 (USD Million) 11.2.4.2.2. Germany market, by By End-User, 2021-2030 (USD Million) 11.2.4.2.3. Germany market, by Type of Animal, 2021-2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France market, by By Product, 2021-2030 (USD Million) 11.2.4.3.2. France market, by By End-User, 2021-2030 (USD Million) 11.2.4.3.3. France market, by Type of Animal, 2021-2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe market, by By Product, 2021-2030 (USD Million) 11.2.4.4.2. Rest of Europe market, by By End-User, 2021-2030 (USD Million) 11.2.4.4.3. Rest of Europe market, by Type of Animal, 2021-2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific market, by By Product, 2021-2030 (USD Million) 11.3.2. Asia Pacific market, by By End-User, 2021-2030 (USD Million) 11.3.3. Asia Pacific market, by Type of Animal, 2021-2030 (USD Million) 11.3.4. Asia Pacific market, by country, 2021-2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China market, by By Product, 2021-2030 (USD Million) 11.3.4.1.2. China market, by By End-User, 2021-2030 (USD Million) 11.3.4.1.3. China market, by Type of Animal, 2021-2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India market, by By Product, 2021-2030 (USD Million) 11.3.4.2.2. India market, by By End-User, 2021-2030 (USD Million) 11.3.4.2.3. India market, by Type of Animal, 2021-2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan market, by By Product, 2021-2030 (USD Million) 11.3.4.3.2. Japan market, by By End-User, 2021-2030 (USD Million) 11.3.4.3.3. Japan market, by Type of Animal, 2021-2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea market, by By Product, 2021-2030 (USD Million) 11.3.4.4.2. South Korea market, by By End-User, 2021-2030 (USD Million) 11.3.4.4.3. South Korea market, by Type of Animal, 2021-2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC market, by By Product, 2021-2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC market, by By End-User, 2021-2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC market, by Type of Animal, 2021-2030 (USD Million) 11.4. Latin America 11.4.1. Latin America market, by By Product, 2021-2030 (USD Million) 11.4.2. Latin America market, by By End-User, 2021-2030 (USD Million) 11.4.3. Latin America market, by Type of Animal, 2021-2030 (USD Million) 11.4.4. Latin America market, by country, 2021-2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil market, by By Product, 2021-2030 (USD Million) 11.4.4.1.2. Brazil market, by By End-User, 2021-2030 (USD Million) 11.4.4.1.3. Brazil market, by Type of Animal, 2021-2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico market, by By Product, 2021-2030 (USD Million) 11.4.4.2.2. Mexico market, by By End-User, 2021-2030 (USD Million) 11.4.4.2.3. Mexico market, by Type of Animal, 2021-2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin America market, by By Product, 2021-2030 (USD Million) 11.4.4.3.2. Rest of the Latin America market, by By End-User, 2021-2030 (USD Million) 11.4.4.3.3. Rest of the Latin America market, by Type of Animal, 2021-2030 (USD Million) 11.5. MEA 11.5.1. MEA market, by By Product, 2021-2030 (USD Million) 11.5.2. MEA market, by By End-User, 2021-2030 (USD Million) 11.5.3. MEA market, by Type of Animal, 2021-2030 (USD Million) 11.5.4. MEA market, by Region, 2021-2030 (USD Million) 12. Competitive Landscape 12.1 Bruker 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. Product Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. General Electric 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Product Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. Koninklijke Philips N.V. 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Product Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. Hitachi Ltd 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Product Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. Siemens Healthcare GmbH 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Product Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. FUJIFILM Corporation 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Product Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. PerkinElmer Inc 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Product Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. Clarius Mobile Health 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Product Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. Shenzhen Ricso Technology Co. Ltd 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Product Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. DRAMIÑSKI SA 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. Product Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. Epica Animal Health 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. Product Portfolio Analysis 12.11.4. Business Strategy & Recent Development 12.12. ClearVet Digital Radiography Systems. 12.12.1. Company overview 12.12.2. Financial performance 12.12.3. Product Portfolio Analysis 12.12.4. Business Strategy & Recent Development 12.13. MinXray Inc 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Product Portfolio Analysis 12.13.4. Business Strategy & Recent Development 12.14. Hallmarq Veterinary Imaging 12.14.1. Company overview 12.14.2. Financial performance 12.14.3. Product Portfolio Analysis 12.14.4. Business Strategy & Recent Development 12.15. Shantou Institute of Ultrasonic Instruments Co., Ltd 12.15.1. Company overview 12.15.2. Financial performance 12.15.3. Product Portfolio Analysis 12.15.4. Business Strategy & Recent Development 12.16. Sonoscape Medical Corp 12.16.1. Company overview 12.16.2. Financial performance 12.16.3. Product Portfolio Analysis 12.16.4. Business Strategy & Recent Development 12.17. Reproscan 12.17.1. Company overview 12.17.2. Financial performance 12.17.3. Product Portfolio Analysis 12.17.4. Business Strategy & Recent Development List of Tables (61 Tables) TABLE 1. MARKET, By Product, 2021-2030 (USD Million) TABLE 2. MARKET FOR Instrument, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Reagents, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Services, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Veterinary PACS, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET, By End-User, 2021-2030 (USD Million) TABLE 7. MARKET FOR Reference Laboratories, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Clinics, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET, BY TYPE OF ANIMAL, 2021-2030 (USD Million) TABLE 11. MARKET FOR Large Animals, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Small Companion Animals, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET, BY Application, 2021-2030 (USD Million) TABLE 14. MARKET FOR Oncology, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Orthopaedics and Traumatology, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Neurology, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Cardiology, BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET FOR Other (ophthalmology & dentistry), BY REGION, 2021-2030 (USD Million) TABLE 19. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA MARKET, BY TYPE OF ANIMAL, 2021-2030 (USD Million) TABLE 24. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. EUROPE MARKET, By Product, 2021-2030 (USD Million) TABLE 26. EUROPE MARKET, By End-User, 2021-2030 (USD Million) TABLE 27. EUROPE MARKET, BY TYPE OF ANIMAL, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC MARKET, BY TYPE OF ANIMAL, 2021-2030 (USD Million) TABLE 32. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 33. LAMEA MARKET, By Product, 2021-2030 (USD Million) TABLE 34. LAMEA MARKET, By Application, 2021-2030 (USD Million) TABLE 35. LAMEA MARKET, BY TYPE OF ANIMAL, 2021-2030 (USD Million) TABLE 36. Bruker: COMPANY SNAPSHOT TABLE 37. Bruker: OPERATING SEGMENTS TABLE 38. General Electric: COMPANY SNAPSHOT TABLE 39. General Electric: OPERATING SEGMENTS TABLE 40. Koninklijke Philips N.V.: COMPANY SNAPSHOT TABLE 41. Koninklijke Philips N.V.: OPERATING SEGMENTS TABLE 42. Hitachi Ltd.: COMPANY SNAPSHOT TABLE 43. Hitachi Ltd.: OPERATING SEGMENTS TABLE 44. Siemens Healthcare GmbH: COMPANY SNAPSHOT TABLE 45. Siemens Healthcare GmbH: OPERATING SEGMENTS TABLE 46. DRAMIÑSKI SA: COMPANY SNAPSHOT TABLE 47. DRAMIÑSKI SA: OPERATING SEGMENTS TABLE 48. Epica Animal Health: COMPANY SNAPSHOT TABLE 49. Epica Animal Health: OPERATING SEGMENTS TABLE 50. ClearVet Digital Radiography Systems: COMPANY SNAPSHOT TABLE 51. ClearVet Digital Radiography Systems: OPERATING SEGMENTS TABLE 52. MinXray Inc: COMPANY SNAPSHOT TABLE 53. MinXray Inc: OPERATING SEGMENTS TABLE 54. Hallmarq Veterinary Imaging: COMPANY SNAPSHOT TABLE 55. Hallmarq Veterinary Imaging: OPERATING SEGMENTS TABLE 56. Shantou Institute of Ultrasonic Instruments Co., Ltd: COMPANY SNAPSHOT TABLE 57. Shantou Institute of Ultrasonic Instruments Co., Ltd: OPERATING SEGMENTS TABLE 58. Sonoscape Medical Corp: COMPANY SNAPSHOT TABLE 59. Sonoscape Medical Corp: OPERATING SEGMENTS TABLE 60. Reproscan: COMPANY SNAPSHOT TABLE 61. Reproscan: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 11 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Veterinary Imaging Market, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Veterinary Imaging Market, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Type of Animal, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 Instrument to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 17 Small Companion Animals to Witness Higher CAGR in Market for Type of Animal Segment during Forecast Period. Figure 18 veterinary hospitals to Witness Higher CAGR in the Market for End-User Segment during Forecast Period. Figure 19 Orthopaedics and Traumatology to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview